A New Approach for the Prophylactic Improvement of Surgical Scarring: Avotermin (TGFβ3)

Patients and physicians are concerned about scarring resulting from surgery, and patients, in particular, value even small improvements in scarring. Translational research into the processes involved in scarring at the molecular, cellular, and tissue levels has facilitated the discovery and development of new biological approaches for improving scarring. This article highlights research concerning avotermin (human recombinant TGFβ3), the first in a new class of prophylactic medicines that may promote the regeneration of normal skin and improve scar appearance.